Effect of Intraoperative Infusion of Esketamine on Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized Controlled Trial

Abstract Introduction This study aims to evaluate the efficacy of esketamine on postoperative recovery quality after laparoscopic bariatric surgery. Methods Patients (n = 74) scheduled for laparoscopic bariatric surgery were randomly divided into two groups: the esketamine group (group E: 0.5 mg/kg/...

Full description

Bibliographic Details
Main Authors: Jingyue Zhang, Fan Wang, Jingjing Dang, Huiwen Zheng, Baiqing Ren, Chao Liu, Ronghua Zuo, Rui Wang, Tianya Liu, Zhiping Wang
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-05-01
Series:Pain and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40122-023-00519-9
_version_ 1797795884541411328
author Jingyue Zhang
Fan Wang
Jingjing Dang
Huiwen Zheng
Baiqing Ren
Chao Liu
Ronghua Zuo
Rui Wang
Tianya Liu
Zhiping Wang
author_facet Jingyue Zhang
Fan Wang
Jingjing Dang
Huiwen Zheng
Baiqing Ren
Chao Liu
Ronghua Zuo
Rui Wang
Tianya Liu
Zhiping Wang
author_sort Jingyue Zhang
collection DOAJ
description Abstract Introduction This study aims to evaluate the efficacy of esketamine on postoperative recovery quality after laparoscopic bariatric surgery. Methods Patients (n = 74) scheduled for laparoscopic bariatric surgery were randomly divided into two groups: the esketamine group (group E: 0.5 mg/kg/h infusion, i.e., 0.2 mL/kg/h) or the control group (group C: 0.2 mL/kg/h normal saline infusion). The infusions were stopped 20 min before the end of the procedure. The primary outcome was the Quality of Recovery-40 (QoR-40) score on postoperative day 1 (POD 1). The secondary outcomes included QoR-40 scores on PODs 2 and 7, Numeric Rating Scale (NRS) on PODs 1, 2, and 7, time to extubation, additional postoperative analgesic use, length of hospital stay, and time to first exhaust. Additonally, the safety indices were also recorded, including hemodynamic profile, perioperative anesthesia index (Ai), utilization of vasoactive drugs or urapidil, and side effects. Results All in all, 70 of the 74 patients completed the study, 35 in each group. The difference of QoR-40 scores on POD 1 was both statistically and clinically significant [difference 7.21, 95% confidence interval (CI) 5.17, 9.25, p < 0.001]. The difference of QoR-40 on POD 2 was statistically significant but clinically insignificant (difference 4.81, 95% CI 2.69, 6.92, p < 0.001). The difference of NRS scores on POD 1 was statistically significant (difference −1.23, 95% CI −2.36, −0.10, p = 0.033). Compared with group C, group E had a lower utilization rate of phenylephrine and higher Ai values (p < 0.05). There was no statistical difference between the two groups on other measures. Conclusion Continuous ketamine infusion seems to be safe and well tolerated in laparoscopic bariatric surgery. It improved the quality of postoperative recovery and reduced pain on POD 1. In spite of the increased Ai value during the surgery, it also provided better hemodynamics with less usage of phenylephrine.
first_indexed 2024-03-13T03:24:46Z
format Article
id doaj.art-e91ff9b084a04053b0af62cb6fb740df
institution Directory Open Access Journal
issn 2193-8237
2193-651X
language English
last_indexed 2024-03-13T03:24:46Z
publishDate 2023-05-01
publisher Adis, Springer Healthcare
record_format Article
series Pain and Therapy
spelling doaj.art-e91ff9b084a04053b0af62cb6fb740df2023-06-25T11:08:21ZengAdis, Springer HealthcarePain and Therapy2193-82372193-651X2023-05-0112497999210.1007/s40122-023-00519-9Effect of Intraoperative Infusion of Esketamine on Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized Controlled TrialJingyue Zhang0Fan Wang1Jingjing Dang2Huiwen Zheng3Baiqing Ren4Chao Liu5Ronghua Zuo6Rui Wang7Tianya Liu8Zhiping Wang9Department of Anesthesiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital of Xuzhou Medical UniversityAbstract Introduction This study aims to evaluate the efficacy of esketamine on postoperative recovery quality after laparoscopic bariatric surgery. Methods Patients (n = 74) scheduled for laparoscopic bariatric surgery were randomly divided into two groups: the esketamine group (group E: 0.5 mg/kg/h infusion, i.e., 0.2 mL/kg/h) or the control group (group C: 0.2 mL/kg/h normal saline infusion). The infusions were stopped 20 min before the end of the procedure. The primary outcome was the Quality of Recovery-40 (QoR-40) score on postoperative day 1 (POD 1). The secondary outcomes included QoR-40 scores on PODs 2 and 7, Numeric Rating Scale (NRS) on PODs 1, 2, and 7, time to extubation, additional postoperative analgesic use, length of hospital stay, and time to first exhaust. Additonally, the safety indices were also recorded, including hemodynamic profile, perioperative anesthesia index (Ai), utilization of vasoactive drugs or urapidil, and side effects. Results All in all, 70 of the 74 patients completed the study, 35 in each group. The difference of QoR-40 scores on POD 1 was both statistically and clinically significant [difference 7.21, 95% confidence interval (CI) 5.17, 9.25, p < 0.001]. The difference of QoR-40 on POD 2 was statistically significant but clinically insignificant (difference 4.81, 95% CI 2.69, 6.92, p < 0.001). The difference of NRS scores on POD 1 was statistically significant (difference −1.23, 95% CI −2.36, −0.10, p = 0.033). Compared with group C, group E had a lower utilization rate of phenylephrine and higher Ai values (p < 0.05). There was no statistical difference between the two groups on other measures. Conclusion Continuous ketamine infusion seems to be safe and well tolerated in laparoscopic bariatric surgery. It improved the quality of postoperative recovery and reduced pain on POD 1. In spite of the increased Ai value during the surgery, it also provided better hemodynamics with less usage of phenylephrine.https://doi.org/10.1007/s40122-023-00519-9Bariatric surgeryEsketaminePostoperative painPostoperative recoveryQuality of Recovery-40Quality measures
spellingShingle Jingyue Zhang
Fan Wang
Jingjing Dang
Huiwen Zheng
Baiqing Ren
Chao Liu
Ronghua Zuo
Rui Wang
Tianya Liu
Zhiping Wang
Effect of Intraoperative Infusion of Esketamine on Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized Controlled Trial
Pain and Therapy
Bariatric surgery
Esketamine
Postoperative pain
Postoperative recovery
Quality of Recovery-40
Quality measures
title Effect of Intraoperative Infusion of Esketamine on Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized Controlled Trial
title_full Effect of Intraoperative Infusion of Esketamine on Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized Controlled Trial
title_fullStr Effect of Intraoperative Infusion of Esketamine on Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized Controlled Trial
title_full_unstemmed Effect of Intraoperative Infusion of Esketamine on Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized Controlled Trial
title_short Effect of Intraoperative Infusion of Esketamine on Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized Controlled Trial
title_sort effect of intraoperative infusion of esketamine on quality of postoperative recovery in patients undergoing laparoscopic bariatric surgery a randomized controlled trial
topic Bariatric surgery
Esketamine
Postoperative pain
Postoperative recovery
Quality of Recovery-40
Quality measures
url https://doi.org/10.1007/s40122-023-00519-9
work_keys_str_mv AT jingyuezhang effectofintraoperativeinfusionofesketamineonqualityofpostoperativerecoveryinpatientsundergoinglaparoscopicbariatricsurgeryarandomizedcontrolledtrial
AT fanwang effectofintraoperativeinfusionofesketamineonqualityofpostoperativerecoveryinpatientsundergoinglaparoscopicbariatricsurgeryarandomizedcontrolledtrial
AT jingjingdang effectofintraoperativeinfusionofesketamineonqualityofpostoperativerecoveryinpatientsundergoinglaparoscopicbariatricsurgeryarandomizedcontrolledtrial
AT huiwenzheng effectofintraoperativeinfusionofesketamineonqualityofpostoperativerecoveryinpatientsundergoinglaparoscopicbariatricsurgeryarandomizedcontrolledtrial
AT baiqingren effectofintraoperativeinfusionofesketamineonqualityofpostoperativerecoveryinpatientsundergoinglaparoscopicbariatricsurgeryarandomizedcontrolledtrial
AT chaoliu effectofintraoperativeinfusionofesketamineonqualityofpostoperativerecoveryinpatientsundergoinglaparoscopicbariatricsurgeryarandomizedcontrolledtrial
AT ronghuazuo effectofintraoperativeinfusionofesketamineonqualityofpostoperativerecoveryinpatientsundergoinglaparoscopicbariatricsurgeryarandomizedcontrolledtrial
AT ruiwang effectofintraoperativeinfusionofesketamineonqualityofpostoperativerecoveryinpatientsundergoinglaparoscopicbariatricsurgeryarandomizedcontrolledtrial
AT tianyaliu effectofintraoperativeinfusionofesketamineonqualityofpostoperativerecoveryinpatientsundergoinglaparoscopicbariatricsurgeryarandomizedcontrolledtrial
AT zhipingwang effectofintraoperativeinfusionofesketamineonqualityofpostoperativerecoveryinpatientsundergoinglaparoscopicbariatricsurgeryarandomizedcontrolledtrial